Opportunity Information: Apply for RFA IP 11 012
Apply for RFA IP 11 012
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 29, 2010 and posted on Dec 29, 2010.
- Applicants must submit their applications by Mar 15, 2011 On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM Eastern Time. Note.HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility is limited to All India Institute of Medical Science (AIIMS), an autonomous Institution within the Indian Ministry of Health and Family Affairs, India. Please see the eligibility section of the announcement for further details.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India" (Funding Opportunity Number RFA IP 11 012), is a CDC cooperative agreement intended to build and strengthen India s capacity to detect, characterize, and evaluate respiratory infectious diseases. It is sponsored by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, specifically the National Center for Immunization and Respiratory Diseases (NCIRD) Influenza Division. The overall purpose is to improve the ability to identify both existing and emerging respiratory pathogens, measure how much illness they cause, and generate evidence that can guide prevention strategies such as vaccination and other public health interventions.
A central focus of the opportunity is improving understanding of the burden and epidemiology of acute respiratory tract infections among both children and adults in India, including infections caused by important viral and bacterial pathogens. The CDC highlights that India experiences a high incidence of respiratory infections and substantial susceptibility in the population, which creates a valuable setting for learning more about how these diseases spread, who is most affected, and what factors shape severe outcomes. Because respiratory pathogens circulate globally and can evolve quickly, the work supported under this agreement is positioned not only as a national benefit for India but also as a contribution to global health security, especially when it comes to early identification of threats that could spread internationally.
The project is also designed to support evaluation of preventive tools, with explicit attention to vaccines. That includes assessing vaccine acceptability in relevant communities and patient groups, and evaluating vaccine efficacy and real world effectiveness where appropriate. In addition to vaccines, the opportunity calls for examining other interventions that could reduce respiratory disease burden, which can include clinical and public health measures aimed at limiting transmission, protecting high risk groups, and improving outcomes during outbreaks. A recurring emphasis is the need to be prepared for a range of influenza threats, including seasonal influenza as well as pandemic potential strains and avian influenza, while also maintaining the flexibility to detect new or re emerging respiratory diseases of possible global importance.
Administratively, this is a discretionary funding opportunity using a cooperative agreement mechanism, meaning the CDC would expect substantial involvement in technical direction, collaboration, and oversight rather than operating as a hands off funder. The activity category is health, and the CFDA number listed is 93.283 (CDC Investigations and Technical Assistance). The announcement anticipated one award, and there was no cost sharing or matching requirement. Eligibility is narrowly restricted to a single institution: the All India Institute of Medical Sciences (AIIMS), described as an autonomous institution within the Indian Ministry of Health and Family Welfare. In practical terms, this makes the opportunity a targeted partnership rather than an open competition among many applicants.
Key dates in the posting show it was published on December 29, 2010, with an original and current closing date of March 15, 2011, and an archive date of April 14, 2011. The submission instructions stressed that applications had to be electronically submitted and fully validated through Grants.gov and eRA Commons by 5:00 PM Eastern Time on the deadline date, and that CDC procedures did not provide an error correction window after the deadline. Award floor and ceiling amounts were listed as zero in the summary fields, which typically indicates that funding amounts were either specified elsewhere in the full announcement or not captured in the summary extract.
For assistance, the listed contact point was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), with a phone number provided (770 488 2700). Overall, the opportunity reflects a strategic CDC AIIMS collaboration aimed at strengthening surveillance and applied research on respiratory pathogens in India, generating data on disease burden, and supporting evidence based decisions about vaccines and other interventions, with particular relevance to influenza and other emerging respiratory threats.
Frequently Asked Questions (FAQs)
1. What is the title of this grant opportunity?
The opportunity is titled "Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India."
2. What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA IP 11 012.
3. What type of funding mechanism is being used?
This is a CDC cooperative agreement. That mechanism is designed for projects where the CDC expects substantial involvement, including technical direction, collaboration, and oversight, rather than acting as a hands-off funder.
4. Which U.S. agency is sponsoring this opportunity?
The sponsor is the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).
5. Which part of CDC is responsible for this award?
The opportunity is associated with the National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division.
6. What is the overall purpose of this cooperative agreement?
The overall purpose is to build and strengthen India’s capacity to detect, characterize, and evaluate respiratory infectious diseases, including both existing and emerging respiratory pathogens.
7. What public health needs is the project intended to address?
The project emphasizes improving the ability to identify respiratory pathogens, measure how much illness they cause (disease burden), and generate evidence that can guide prevention strategies such as vaccination and other public health interventions.
8. What infections and populations are a central focus of the work?
A central focus is acute respiratory tract infections among both children and adults in India, including infections caused by important viral and bacterial pathogens.
9. Why is India highlighted as an important setting for this work?
The announcement notes that India experiences a high incidence of respiratory infections and substantial susceptibility in the population, making it a valuable setting to learn more about transmission, who is most affected, and what factors contribute to severe outcomes.
10. How does this work relate to global health security?
The opportunity frames this work as beneficial for India and also relevant to global health security, because respiratory pathogens circulate globally and can evolve quickly, and early identification of threats can help when risks may spread internationally.
11. What kinds of pathogens or threats are specifically emphasized?
The opportunity highlights preparedness for a range of influenza threats, including seasonal influenza, strains with pandemic potential, and avian influenza, while maintaining flexibility to detect new or re-emerging respiratory diseases of possible global importance.
12. Does the opportunity include vaccine-related activities?
Yes. The project is designed to support evaluation of preventive tools with explicit attention to vaccines, including assessing vaccine acceptability in relevant communities and patient groups, and evaluating vaccine efficacy and real-world effectiveness where appropriate.
13. Are non-vaccine interventions part of the scope?
Yes. The opportunity calls for examining other interventions that could reduce respiratory disease burden, including clinical and public health measures aimed at limiting transmission, protecting high-risk groups, and improving outcomes during outbreaks.
14. What is the activity category for this funding opportunity?
The activity category is health.
15. What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.283 (CDC Investigations and Technical Assistance).
16. How many awards were anticipated?
The announcement anticipated one award.
17. Is cost sharing or matching required?
No. The opportunity states there was no cost sharing or matching requirement.
18. Who is eligible to apply?
Eligibility is narrowly restricted to a single institution: the All India Institute of Medical Sciences (AIIMS), described as an autonomous institution within the Indian Ministry of Health and Family Welfare.
19. Is this an open competition for multiple organizations?
No. Based on the stated eligibility restriction to AIIMS, this is structured as a targeted partnership rather than an open competition among many applicants.
20. When was this opportunity posted?
The posting date was December 29, 2010.
21. What was the application deadline?
The original and current closing date listed was March 15, 2011.
22. What time were applications due on the deadline date?
Applications had to be electronically submitted and fully validated through Grants.gov and eRA Commons by 5:00 PM Eastern Time on the deadline date.
23. Were applicants given time to correct errors after the deadline?
No. The submission instructions stressed that CDC procedures did not provide an error correction window after the deadline.
24. When was the opportunity archived?
The archive date listed was April 14, 2011.
25. What electronic systems were required for submission and validation?
The instructions required electronic submission and full validation through Grants.gov and eRA Commons.
26. What are the listed award floor and ceiling amounts?
The award floor and ceiling amounts were listed as zero in the summary fields, which typically indicates the funding amounts were specified elsewhere in the full announcement or were not captured in the summary extract.
27. Who can be contacted for assistance with this opportunity?
The listed contact point was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
28. What is the phone number for the listed contact?
The phone number provided was 770 488 2700.
Browse more opportunities from the same category: Health
Next opportunity: OJJDP FY 2011 National Mentoring Programs
Previous opportunity: Technical Assistance and Capacity Building under the Transformation Initiative Request for Qualifications
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 11 012
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 11 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| Influenza Vaccine Efficacy in Tropical and Developing Countries Apply for RFA IP 11 013 Funding Number: RFA IP 11 013 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantee Sites Apply for HRSA 11 101 Funding Number: HRSA 11 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Sustainable Responses for Improving the Lives of Vulnerable Children and their Households Apply for RFA 617 11 000001 Funding Number: RFA 617 11 000001 Agency: Uganda USAID Kampala Category: Health Funding Amount: $29,500,000 |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Apply for PA 11 087 Funding Number: PA 11 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Apply for PA 11 088 Funding Number: PA 11 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Apply for PA 11 089 Funding Number: PA 11 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NHLBI Investigator Initiated Resource Related Research Projects (R24) Apply for PAR 11 090 Funding Number: PAR 11 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Access to Emergency Devices Apply for HRSA 11 088 Funding Number: HRSA 11 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Emerging Infections Sentinel Network (EISN) Research Apply for RFA CK 11 002 Funding Number: RFA CK 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $407,000 |
| Effectiveness in an Intervention to Promote a Targeted Vaccination Program in the Obstetrician Gynecologist Setting Apply for RFA IP 11 009 Funding Number: RFA IP 11 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| National Center for Chronic Disease Prevention and Health Promotion Conference Support Program Apply for CDC RFA DP11 1102 Funding Number: CDC RFA DP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Genomic Resource Grants for Community Resource Projects (U41) Apply for PAR 11 095 Funding Number: PAR 11 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhanced Surveillance for New Vaccine Preventable Disease Apply for RFA IP 11 010 Funding Number: RFA IP 11 010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Affordable Care Act Health Center Planning Grants Apply for HRSA 11 021 Funding Number: HRSA 11 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States Apply for RFA IP 11 003 Funding Number: RFA IP 11 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $785,000 |
| Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools. Apply for RFA IP 11 006 Funding Number: RFA IP 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Economic Studies of Vaccines and Immunization Policies, Programs and Practices Apply for RFA IP 11 007 Funding Number: RFA IP 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The Incidence and Etiology of Influenza Associated Community Acquired Pneumonia in Hospitalized Persons Study Apply for RFA IP 11 011 Funding Number: RFA IP 11 011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Conference Support Program Apply for CDC RFA EH11 1105 Funding Number: CDC RFA EH11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Service Area Competition Additional Areas Apply for HRSA 11 163 Funding Number: HRSA 11 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 11 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.